New drug trial aims to save insulin cells in type 1 diabetes
NCT ID NCT07258394
Summary
This study is testing whether an oral medication called dimethyl fumarate can help protect the body's remaining insulin-producing cells in adults recently diagnosed with type 1 diabetes. Researchers will compare the drug to a placebo in 90 participants over 24 weeks to see if it slows the disease's progression. The main goal is to see if patients can maintain more of their own natural insulin production, which could reduce their dependence on injected insulin.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Deparement of Endocrinology and Metabolism, The First Affiliated Hospital with Nanjing Medical University
RECRUITINGNanjing, Jiangsu, 210029, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.